Physician profile
Caleb K Morris
NPI 1316359524
$4,361.98
in general payments reported to CMS, 2019-2025
17 companies · $946 in 2025
The $946 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.44 · 2021: $489 · 2022: $839 · 2023: $1,008 · 2024: $1,019 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,919 · Honoraria: $53.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,919.48 |
| Honoraria | $53.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,079.01 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Rxsight INC | $1,357.45 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $242.33 | 2021-2024 | Idose |
| Rayner Intraocular Lenses Limited | $181.50 | 2022-2024 | Omidria, Rayone Aspheric, Rayone Emv |
| Biotissue Holdings INC. | $131.08 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $61.51 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $60.00 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $58.50 | 2021-2025 | Tecnis Iol |
| Dompe US, INC. | $34.85 | 2021-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.36 | 2021 | |
| Allergan, INC. | $22.88 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.57 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $21.23 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $20.33 | 2022 | |
| Shire North American Group INC | $15.87 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $15.50 | 2019 | |
| Sight Sciences, INC. | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.